myeloma - dofaq.co
Elranatamab y teclistamab, nuevos fármacos disponibles en España para el mieloma múltiple
Farmacosalud - 30 Apr 2024
Elranatamab y teclistamab, nuevos fármacos disponibles en España para el mieloma múltiple ...
★ Disponible en España ▼TECVAYLI® (teclistamab), el primer anticuerpo biespecífico anti- BCMA
Vademecum - 30 Apr 2024
★ Disponible en España ▼TECVAYLI® (teclistamab), el primer anticuerpo biespecífico anti- BCMA ...
Myeloma UK Award to Manchester Royal Infirmary Haemotology Department
Manchester University NHS Foundation Trust - 01 May 2024
Myeloma UK Award to Manchester Royal Infirmary Haemotology Department ...
Managing Cranial Nerve Impairment in Multiple Myeloma Following Cilta-cel
Cancer Network - 01 May 2024
Managing Cranial Nerve Impairment in Multiple Myeloma Following Cilta-cel ...
Targeting myeloma essential genes using NOT Gated CAR T-cells, a computational approach | Leukemia
Nature - 30 Apr 2024
Targeting myeloma essential genes using NOT Gated CAR T-cells, a computational approach | Leukemia ...
Mieloma múltiple: el tipo de cáncer raro que tiene el dolor de espalda como principal síntoma
BBC.com - 31 May 2022
Mieloma múltiple: el tipo de cáncer raro que tiene el dolor de espalda como principal síntoma ...
Clinical Benefits, But Not Improved ORR, Seen With KPd in Lenalidomide-Refractory Multiple Myeloma
Hematology Advisor - 01 May 2024
Clinical Benefits, But Not Improved ORR, Seen With KPd in Lenalidomide-Refractory Multiple Myeloma ...
15th International Myeloma Foundation gala raises over $675K
Myeloma Research News - 30 Apr 2024
15th International Myeloma Foundation gala raises over $675K ...
Dr Anderson on the FDA ODAC Decision Regarding Cilta-Cel in R/R Multiple Myeloma
OncLive - 29 Apr 2024
Dr Anderson on the FDA ODAC Decision Regarding Cilta-Cel in R/R Multiple Myeloma ...
Daratumumab Plus Standard Therapy for Multiple Myeloma
National Cancer Institute - 19 Jan 2024
Daratumumab Plus Standard Therapy for Multiple Myeloma ...
Cranial Nerve Palsy May Be Present After Cilta-Cel for Multiple Myeloma
Oncology Nursing News - 27 Apr 2024
Cranial Nerve Palsy May Be Present After Cilta-Cel for Multiple Myeloma ...
Mayo Clinic Minute: Advances in multiple myeloma treatment
Mayo Clinic - 12 Mar 2024
Mayo Clinic Minute: Advances in multiple myeloma treatment ...
What Is a FISH Test in Multiple Myeloma?
HealthTree - 22 Apr 2024
What Is a FISH Test in Multiple Myeloma? ...
Rheological properties of blood in multiple myeloma patients | Scientific Reports
Nature - 21 Feb 2024
Rheological properties of blood in multiple myeloma patients | Scientific Reports ...
ODAC Decisions Confirm Benefit of Ide-Cel and Cilta-Cel in Earlier Line R/R Myeloma Therapy
OncLive - 25 Apr 2024
ODAC Decisions Confirm Benefit of Ide-Cel and Cilta-Cel in Earlier Line R/R Myeloma Therapy ...
Discussing Myeloma Research With Dr. Adeel Khan
HealthTree - 25 Apr 2024
Discussing Myeloma Research With Dr. Adeel Khan ...
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review | Blood Cancer Journal
Nature - 25 Jan 2024
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review | Blood Cancer Journal ...
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study | Blood Cancer Journal
Nature - 05 Mar 2024
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study | Blood Cancer Journal ...
Redefining high risk multiple myeloma with an APOBEC/Inflammation-based classifier | Leukemia
Nature - 09 Mar 2024
Redefining high risk multiple myeloma with an APOBEC/Inflammation-based classifier | Leukemia ...